Reviva Pharmaceuticals files preliminary proxy statement
Reviva Pharmaceuticals filed a preliminary proxy statement dated October 29. The headline lists a date of Dec. 18.
Related stories
Strategy CFO Resigns as Company Reports Record Quarterly Profit
Strategy shares fell 6%. The supplied report does not identify the CFO or provide details on the quarterly profit.
M impact | EQUITY | Oct 30, 2026, 09:41 AM UTC
Prudential raises deemed stake in Solarvest to 5.646%
Prudential increased its deemed stake in Solarvest to 5.646%.
M impact | EQUITY | Oct 30, 2026, 09:41 AM UTC
China’s Xi and Swiss President Praise Trade Deal Boosting Market Access
China’s Xi and the Swiss president praised a trade deal that boosts access.
M impact | EQUITY | Oct 30, 2026, 09:38 AM UTC
Foxconn Works on New Partnership With OpenAI, Rejects AI Bubble Label
Foxconn says it is working on a new partnership with OpenAI and says there is no AI bubble.
M impact | EQUITY | Oct 30, 2026, 09:38 AM UTC
Foxconn Discusses New Collaboration With OpenAI
Foxconn is discussing a new collaboration with OpenAI. It also said there is no AI bubble.
M impact | EQUITY | Oct 30, 2026, 09:38 AM UTC
Amazon Shares Slump Before Open as Q3 Earnings Fall
Amazon’s Q3 earnings fell despite higher revenue, while free cash outflow reached $42.4 billion.
M impact | EQUITY | Oct 30, 2026, 09:35 AM UTC